Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Miro1 mutations disrupt cellular calcium homeostasis via dysregulation of mitochondria-ER-contact-sites, rendering iPSC-derived neurons more susceptible to lipid peroxidation.

Neurobiology of disease·2026
Same author

Cognitive and Neuroimaging Divergence Between Juvenile and Adult FUS Amyotrophic Lateral Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

VAPB confers selective neuroprotection by driving autophagic degradation of pathogenic aggregates in ALS.

Acta neuropathologica communications·2026
Same author

Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Annals of neurology·2026
Same author

Impact of Plasma p-tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS.

Annals of clinical and translational neurology·2026

Related Experiment Video

Updated: Jan 14, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.0K

Benchmarking large language models for personalized, biomarker-based health intervention recommendations.

Hans Jarchow1, Christoph Bobrowski2, Steffi Falk3

  • 1Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany.

NPJ Digital Medicine
|October 28, 2025
PubMed
Summary

Large language models (LLMs) show limited suitability for personalized longevity recommendations. While proprietary models performed better, all LLMs struggled with medical validation, stability, and age biases in this study.

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K

Related Experiment Videos

Last Updated: Jan 14, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.0K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K

Area of Science:

  • Artificial Intelligence in Medicine
  • Biomedical Informatics
  • Computational Biology

Background:

  • Large language models (LLMs) are increasingly used in healthcare, but their effectiveness for personalized longevity interventions is unclear.
  • Existing frameworks for evaluating AI in medicine often do not cover the nuances of generating personalized health recommendations.

Purpose of the Study:

  • To benchmark the performance of LLMs in generating personalized longevity intervention recommendations using the extended BioChatter framework.
  • To assess LLM adherence to critical medical validation requirements for health recommendations.

Main Methods:

  • Developed and utilized an extended BioChatter framework for benchmarking LLMs.
  • Created 1000 diverse test cases from 25 individual profiles across three age groups, covering interventions like caloric restriction, fasting, and supplements.
  • Evaluated 56,000 model responses using an LLM-as-a-Judge system against clinician-validated ground truths.

Main Results:

  • Proprietary LLMs generally outperformed open-source models in comprehensiveness for longevity recommendations.
  • All evaluated LLMs, even with Retrieval-Augmented Generation (RAG), demonstrated limitations in meeting medical validation standards, prompt stability, and addressing age-related biases.
  • The study identified significant challenges in using LLMs for unsupervised generation of longevity advice.

Conclusions:

  • Current LLMs have limited suitability for unsupervised personalized longevity intervention recommendations due to issues with medical validation, stability, and bias.
  • The developed open-source framework provides a foundation for future AI benchmarking in medical applications.
  • Further research is needed to refine LLMs for safe and effective personalized health guidance.